Ozempic-Like Drug Slowed Progression of Parkinson's Disease in New Trial
A stock image of a health care professional holding a syringe.Photo:Getty Getty A promising new trial found that anOzempic-like drug used to treat diabetes might also help patients withParkinson’s disease. Lixisenatide — a glucagon-like peptide-1 receptor agonist like Ozempic and Wegovy — previously showed neuroprotective properties in a mouse model of the degenerative brain condition, according tothe resultsof the phase-two, placebo-controlled human trial, published on April 3 inThe New England Journal of Medicine....